The prodrug developed by researchers caused long-term remission in all murine models of high-risk or drug-resistant cancers with fewer side-effects than a comparable drug.
List view / Grid view
Filter the results
The developers of a novel method to create immunological assay probes for screening T cells has leveraged their new protocol against COVID-19.
A study has discovered that reducing expression of a key gene in neuroblastoma tumourigenesis is an important drug target for the condition.
Paediatric researchers have identified common gene variants that raise the risk of an aggressive forms of childhood cancer...